La hiperglucemia intrahospitalaria es más importante que el antecedente de diabetes para predecir la aparición de desenlaces clínicos adversos en pacientes hospitalizados con COVID-19
Authors:
- Ernesto Ignacio Ferrer-PérezEFErnesto Ignacio Ferrer-Pérez
- David Gabriel David-PardoDDDavid Gabriel David-Pardo
- Ana María Gómez-MedinaAGAna María Gómez-Medina
- Óscar Mauricio Muñoz-VelandiaÓMÓscar Mauricio Muñoz-Velandia
- Darío Parra-PrietoDPDarío Parra-Prieto
- Alfonso Kerguelen-VilladiegoAKAlfonso Kerguelen-Villadiego
- Juan Camilo Salgado-SánchezJSJuan Camilo Salgado-Sánchez
- Jossie Esteban Quijano-NaranjoJQJossie Esteban Quijano-Naranjo
- Ruby Isabel Jojoa-JojoaRJRuby Isabel Jojoa-Jojoa
- Claudia Milena Gómez GiraldoCGClaudia Milena Gómez Giraldo
- Diana Cristina Henao-CarrilloDHDiana Cristina Henao-Carrillo
Open Access
- 23 October 2023
- journal article
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 10 (4)
Abstract
Context: In patients with COVID-19, diabetes mellitus and hyperglycemia are prevalent conditions. The literature is scarce regarding the association of these two variables with unfavorable outcomes in patients hospitalized for COVID-19. Objective: To evaluate the association between hyperglycemia and the occurrence of adverse outcomes in patients with COVID-19. Methodology: Retrospective cohort study evaluating the association between hyperglycemia at presentation with the occurrence of acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and in-hospital death in patients hospitalized with COVID-19. Results: 408 patients were included (mean age 60.48, 58.8% men, 34.1% with diabetes, 40.4% with in-hospital hyperglycemia). Hyperglycemia was independently associated with increased risk of ARDS (OR: 1.84; 95% CI: 1.15-2.94; p=0.001), AKI (OR: 2.73; CI: 1.24-5.96; p=0.012) and in-hospital death (OR: 2.61; CI: 1.20-5.68; p=0.015) after controlling for confounding variables. History of diabetes was not independently associated with increased risk for any of the three adverse outcomes. Conclusions: Hyperglycemia is independently associated with worse outcomes in patients hospitalized for COVID-19, unlike diabetes mellitus. Contexto: en pacientes con COVID-19, la diabetes mellitus y la hiperglucemia son condiciones prevalentes. La literatura es escasa en cuanto a la asociación de estas dos variables con desenlaces desfavorables en pacientes hospitalizados por COVID-19. Objetivo: evaluar la asociación entre hiperglucemia y la aparición de desenlaces adversos en pacientes con COVID-19. Metodología: estudio de cohorte retrospectiva en el que se evaluó la asociación entre presentar hiperglucemia con la aparición de síndrome de dificultad respiratoria aguda (SDRA), lesión renal aguda (LRA) y muerte intrahospitalaria en pacientes hospitalizados por COVID-19. Resultados: se incluyeron 408 pacientes (edad media 60.48, 58.8 % hombres, 34.1 % con diabetes, 40.4 % con hiperglucemia intrahospitalaria). La hiperglucemia se asoció de forma independiente a un mayor riesgo de SDRA (OR: 1.84, IC 95 %: 1.15 – 2.94; p=0.001), LRA (OR: 2.73; IC: 1.24–5.96; p=0.012) y muerte intrahospitalaria (OR: 2.61; IC: 1.20–5.68; p=0.015) después de controlar por variables de confusión. El antecedente de diabetes no se asoció de forma independiente con un mayor riesgo en ninguno de los tres desenlaces adversos. Conclusiones: la hiperglucemia se asocia de forma independiente con peores desenlaces en pacientes hospitalizados por COVID-19 a diferencia de la diabetes mellitus.Keywords
This publication has 12 references indexed in Scilit:
- The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress SyndromeDiabetes Research and Clinical Practice, 2021
- Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 RegistryAnnals of Medicine, 2020
- Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regressionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort studyBMJ Open Diabetes Research & Care, 2020
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Hiperglucemia inducida por estrés en pacientes ancianos hospitalizados no críticosRevista Clínica Española, 2018
- The Berlin definition of ARDS: an expanded rationale, justification, and supplementary materialIntensive Care Medicine, 2012